Pediatric Vaccine Market Growth Is Reshaping Competitive Advantage Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Pediatric Vaccine Market Size Forecast: How Large Could The Market Become By 2030?
The pediatric vaccine market has experienced substantial growth over recent years. Projected to increase from $57.51 billion in 2025 to $65.01 billion in 2026, this expansion reflects a compound annual growth rate (CAGR) of 13.0%. Key factors driving this historical growth include the increasing incidence of preventable childhood diseases, government-backed immunization initiatives, improvements in vaccine adjuvants, heightened awareness around pediatric health, and the development of cold chain infrastructure.
The pediatric vaccine sector is anticipated to experience significant expansion over the coming years. By 2030, the market is projected to reach $107.8 billion, reflecting a compound annual growth rate (CAGR) of 13.5%. This upward trajectory during the forecast period is driven by advancements in mRNA and DNA vaccine technologies, heightened investments in pediatric vaccine research and development, the integration of digital health monitoring tools, the growth of healthcare infrastructure in developing markets, and collaborative efforts between biotechnology companies and global health organizations. Key developments shaping the outlook include a stronger emphasis on vaccine availability in low-income areas, a growing preference for combination vaccines, the broadening of school-based immunization initiatives, the creation of innovative vaccines targeting rare childhood diseases, and the strengthening of public-private partnerships dedicated to vaccine research.
Download A Free Sample Report For Comprehensive Market Insights:
Pediatric Vaccine Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing incidence of chronic illnesses like tuberculosis, diphtheria, and pneumonia among children aged 15 years and under is expected to fuel expansion in the pediatric vaccines market. Complications and severe outcomes from infectious diseases are becoming more frequent in children and adolescents who have chronic health conditions. As an example, data from the National Health Service, a UK government entity, published in June 2024, revealed that 3,615,330 people registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes, characterized by elevated blood sugar levels not reaching diabetic thresholds, in 2023. This figure marked an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the heightened prevalence of chronic conditions is fostering growth in the pediatric vaccine market.
The increasing frequency of pediatric diseases is anticipated to stimulate growth in the pediatric vaccine market over the upcoming period. Pediatric diseases encompass disorders affecting children from infancy through puberty, ranging from moderate to severe in nature and manifesting as either chronic or acute conditions. Vaccinations administered to newborns and children play a vital role in preventing and controlling a broad array of pediatric illnesses, safeguarding them against numerous infectious diseases. For instance, data from GOV.UK, a UK government entity, reported in February 2024 that tuberculosis (TB) cases in England saw a 10.7% increase in 2023, climbing from 4,380 in 2022 to 4,850. Hence, the rising prevalence of pediatric diseases is advancing the pediatric vaccine market forward.
Pediatric Vaccine Market Segmentation: How Is The Market Structured Across Key Categories?
The pediatric vaccine market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Polyvalent Vaccines
Pediatric Vaccine Market Innovation Trends Driving Future Development
Key players in the pediatric vaccine industry are increasingly prioritizing product approvals to address the demands of their current customer base. ABRYSVO, a vaccine cleared by the FDA for administration to pregnant individuals, aims to prevent lower respiratory tract disease (LRTD) and severe LRTD in infants up to six months of age, which are caused by respiratory syncytial virus (RSV). As an example, in August 2023, Pfizer Inc., a pharmaceutical manufacturer based in the United States, disclosed that the U.S. FDA had granted approval for its ABRYSVO vaccine, designed to shield infants from RSV through the active immunization of pregnant women between 32 and 36 weeks of gestation. This marks the first and only maternal immunization sanctioned in the United States to safeguard newborns against LRTD and severe LRTD stemming from RSV, offering protection from birth until they reach six months old.
Pediatric Vaccine Market Competitive Landscape And Leading Companies
Major companies operating in the pediatric vaccine market are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Daiichi Sankyo, CSL Limited, Sinopharm, Walvax Biotechnology, Fosun Pharma, MCM Vaccine Company, Seqirus, Johnson & Johnson, Connaught Laboratories Inc., Wyeth-Ayerst, Ataulfo de Paiva Foundation, Bio-Manguinhos – Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium
Access The Complete Pediatric Vaccine Market Report:
Pediatric Vaccine Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the pediatric vaccine market in 2025. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
